Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by cjdavid1on Jan 16, 2014 11:41am
266 Views
Post# 22099099

Any Level II??

Any Level II??TIA. Looking good for Feb. Conferences. The list of current and potential investors is much longer than I imagined. Upcoming events will open many eyes, and I've heard of this Dr. Calvin Stiller before. Haven't been here in a long time, but all the news, and word-of-mouth around the UNH is very encouraging. I hate looking back, but many of us were stung horribly @ consolidation. I could use this science. I tried to enrol in one their studies. Now, I want more. This train is gathering momentum, IMHO. GLTA Cj
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse